Knight Capital Group Establishes Technical Research Led by Ralph J. Acampora
October 31 2005 - 7:00AM
PR Newswire (US)
JERSEY CITY, N.J., Oct. 31 /PRNewswire-FirstCall/ -- Knight Capital
Group, Inc. (NASDAQ:NITE) today announced the formation of Knight
Technical Research to provide clients with market analysis. Ralph
J. Acampora, an Institutional Investor-ranked technical analyst and
former director of technical research at Prudential Equity Group,
will lead a team of three, also from Prudential. "With Knight
Technical Research, the company will tie technical analysis with
trading for the first time in a series of products for clients,"
said Thomas M. Joyce, Chairman and Chief Executive Officer, Knight
Capital Group. "This analysis is a natural fit into our unbundled
offering to clients who already come to us for our market knowledge
and assistance in making smart trading decisions. I am pleased that
an analyst of Ralph's caliber and experience has chosen to work
with Knight to develop new technical research products for the
market." Mr. Acampora, 64, joined Knight with Peter J. Martin, 42,
Phil N. Choremi, 53, and Peter W. Austin, 25, effective today.
Knight Technical Research will study and evaluate price and volume
momentum along with sentiment and time cycles. They will also apply
these disciplines to the fixed income market as well as to
currencies, commodities and foreign markets. The company expects to
offer clients access to Knight Technical Research before the end of
the year. "Knight's energy and talent attracted me and my team to
the company," Mr. Acampora said. "To Knight's expertise in trade
execution, we bring an expertise in market analysis - the impact of
supply and demand on price. As the buy side looks beyond
fundamental research and further embraces technical analysis,
Knight can add greater value to its clients." Biographies Ralph J.
Acampora, 64, is a well-known and respected technical analyst who
brings to Knight years of experience and accomplishments. He joins
Knight after 15 years as Prudential Securities' Director of
Technical Analysis. He was one of the first technical analysts to
foresee that the Dow Jones Industrial Average would achieve record
gains. Mr. Acampora was named to the 2005 All-America Research
Technical Analysis Third Team in the October 2005 issue of
Institutional Investor. He has consistently been ranked in this
category for the past decade. Prior to his employment at
Prudential, Mr. Acampora worked from 1980 to 1990 at Kidder Peabody
& Co. Before that, he was with Smith Barney, Harris, Upham
& Co. from 1969 to 1980. His financial career began with
Distributor's Group, a mutual fund complex owned by US Life. He
went to Iona College in New Rochelle, New York, and graduated from
St. Joseph's Seminary in Yonkers, New York. He is a Chartered
Market Technician, a designation he helped create and which is now
recognized by the Securities and Exchange Commission. Peter J.
Martin, 42, served in various capacities at Prudential for the past
11 years, most recently as Vice President, Technical Analysis for
Prudential Equity Group, where he provided both the Institutional
and Retail sales forces with in-depth analysis of both domestic and
international markets, sectors, groups and individual securities.
Mr. Martin also provided analysis to portfolio managers and
traders, assisted with the development and presentation of weekly
commentary, and provided technical opinions to fundamental and
quantitative analysts. He earned a bachelor's degree in finance
from Monmouth University, West Long Branch, N.J., and is a
Chartered Market Technician. Phil N. Choremi, 53, comes to Knight
from Prudential Equity Group where, since January 1994, he has
worked directly for Ralph Acampora producing retail and
institutional research. In October 2004, he was named Senior
Technical Analyst and Vice President supporting Listed and Nasdaq
Trading. Prior to working at Prudential, Mr. Choremi was a
technical analyst at Thomson McKinnon Securities. He earned a
bachelor's degree in architecture from the University of
Pennsylvania in Philadelphia. Peter W. Austin, 25, was with
Prudential Equity Group since February 2004 and covered both the
biotechnology industry and the brokerage industry for Prudential
Equity Group, assisting Senior Analysts with the launch of several
small- and mid-cap biotech names as well as sell-side research
coverage of securities firms. He graduated from the University of
Maryland with a bachelor's degree in finance and has completed
Level I of the Chartered Financial Analyst program. About Knight
Knight is a leading provider of comprehensive trade execution and
asset management services. Our Equity Markets business offers
institutions and broker-dealers high quality trade execution and
capital commitment across the depth and breadth of the equity
market. Our Asset Management business, Deephaven Capital
Management, is a multi-strategy investment manager focused on
delivering risk-adjusted returns with low volatility for
institutions and high net worth individuals. Knight strives to be a
valued partner by providing superior service and continually
enhancing its offering to meet client needs. More information about
Knight can be obtained at http://www.knight.com/ . Certain
statements contained herein constitute "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995. These forward-looking statements are based on current
expectations, estimates and projections about the Company's
industry, management's beliefs and certain assumptions made by
management. Readers are cautioned that any such forward-looking
statements are not guarantees of future performance and are subject
to certain risks, uncertainties and assumptions that are difficult
to predict. Since such statements involve risks and uncertainties,
the actual results and performance of the Company may turn out to
be materially different from the results expressed or implied by
such forward-looking statements. Given these uncertainties, readers
are cautioned not to place undue reliance on such forward-looking
statements. Unless otherwise required by law, the Company also
disclaims any obligation to update its view of any such risks or
uncertainties or to announce publicly the result of any revisions
to the forward-looking statements made herein; however, readers
should carefully review reports or documents the Company files from
time to time with the Securities and Exchange Commission including,
without limitation, the risks and uncertainties detailed under the
headings "Certain Factors Affecting Results of Operations" and
"Risks Affecting our Business" in the Company's Annual Report on
Form 10-K. DATASOURCE: Knight Capital Group, Inc. CONTACT: Margaret
Wyrwas, Senior Managing Director, Corporate Communications &
Investor Relations, +1-201-557-6954, , or Kara Fitzsimmons, Vice
President, Corporate Communications, +1-201-356-1523, , or Greta
Morley, Vice President, Marketing Communications & Public
Relations, +1-201-557-6948, , or Molly McDowell, Analyst, Corporate
Communications & Investor Relations, +1-201-356-1723, , all of
Knight Capital Group, Inc. Web site: http://www.knight.com/
Copyright
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Jun 2024 to Jul 2024
Nightstar Therapeutics Plc ADS (NASDAQ:NITE)
Historical Stock Chart
From Jul 2023 to Jul 2024